🇯🇵 Nucala in Japan

PMDA authorised Nucala on 28 March 2016

Marketing authorisation

PMDA — authorised 28 March 2016

  • Marketing authorisation holder: GlaxoSmithKline K.K.
  • Status: approved

Nucala in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in Japan

Frequently asked questions

Is Nucala approved in Japan?

Yes. PMDA authorised it on 28 March 2016.

Who is the marketing authorisation holder for Nucala in Japan?

GlaxoSmithKline K.K. holds the Japanese marketing authorisation.